Safety of multiplex gene testing for inherited cancer risk in a fully accrued prospective trial.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.1576
Abstract: 1576Background: Sequencing more genes increases the chance of finding a pathogenic mutation and/or a variant of uncertain significance (VUS). Little is known about potential harms of multiplex testing for cancer risk, such as unwarranted surgery… read more here.
Keywords: cancer; cancer risk; prospective trial; fully accrued ... See more keywords